Voice Analysis in Men with Benign Prostate Hyperplasia

Year 2023, Volume: 6 Issue: 3, 402 - 405, 31.12.2023

Sedat Alagöz , Vedat Delibaş , Kemal Koray Bal , Ferhat Ortoğlu , Talih Özdaş , Gökhan Kuran , Orhan Görgülü , Betül Kahraman

https://doi.org/10.36516/jocass.1355177

Abstract

Aim: In this study, we aimed to determine the differences by performing voice analysis in men with benign pros-tatic hyperplasia (BPH) and discussing it with the literature
Methods: The study included 77 male patients who came to the urology outpatient clinic and were diagnosed with BPH and consult to us for voice analysis. Patients' ages, testosterone, prostate specific antigen (PSA) levels, prostate volumes (milliliters) were recorded. International prostate symptom scoring (IPSS) was applied to the patients. Mild, moderate, severe patients according to IPSS scoring; were classify as group 1, group 2, group 3, respectively. Voice Handicap Index-10 Turkish version (VHI-10) was realized to the patients and the results were saved.
Results: 77 male patients were accepted to the study. The average age was 60. The mean prostate volume of the patients was 41.1 ml. The IPSS score of the patients was 16 on average. The mean VHI-10 scores were 9.14. The mean PSA levels of the patients were 1.43; testosterone levels were 3.04. F0 Hz (mean pitch) values were 157.74; jitter % values mean 0.26; shimmer % values mean 2.42; The mean HNR dB values were 22.91.
Conclusions: Maybe it would be more logical to think that many local factors, hormones and growth factors are efficient in place of a testosterone.
Keywords: Benign prostatic hyperplasia, voice, analysis, frequency

Keywords

benign prostatic hyperplasia, voice, analysis, frequency

References

• 1.Logozzi M, Angelini DF, Giuliani A, et al. Increased Plasmatic Levels of PSA-Expressing Exosomes Distinguish Prostate Cancer Patients from Be-nign Prostatic Hyperplasia: A Prospective Study. Cancers (Basel). 2019; 11(10): 1449. https://doi.org/10.3390/cancers11101449
• 2.Lein M, Stephan C, Jung K, et al. Relation of free PSA/total PSA in serum for differentiating between patients with prostatic cancer and benign hyper-plasia of the prostate:which cutoff should be used?. Cancer Invest. 1998; 16(1): 45-9. https://doi.org/10.3109/07357909809039753
• 3.Kilic MA, Okur E, Yildirim I, et al. Reliability and validity of the Turkish version of the Voice Handicap Index. Kulak Burun Bogaz Ihtis Derg. 2008; 18(3): 139-47.
• 4.Nanjundeswaran C, Jacobson BH, Gartner-Schmidt J, et al. Vocal Fatigue Index (VFI): Development and Validation. J Voice. 2015; 29(4): 433-40. https://doi.org/10.1016/j.jvoice.2014.09.012
• 5.Kim JM, Shin SC, Park GC, et al. Effect of sex hormones on extracellular matrix of lamina propria in rat vocal fold. Laryngoscope. 2020; 130(3): 732-40. https://doi.org/10.1002/lary.28086 6.Kilic MA. Evaluation of the patient with voice problem by objective and subjective methods. Curr Pract ORL. 2010; 6(2): 257-65. 7.Nacci A, Fattori B, Basolo F, et al. Sex hormone receptors in vocal fold tissue: a theory about the influence of sex hormones in the larynx. Folia Phoniatr Logop. 2011; 63(2): 77-82. https://doi.org/10.1159/000316136
• 8.Ouyoung LM, Villegas BC, Liu C, et al. Effects of Resonance Voice Therapy on Hormone-Related Vocal Disorders in Professional Singers: A Pilot Study. Clin Med Insights Ear Nose Throat. 2018; 11:1179550618786934. https://doi.org/10.1177/1179550618786934
• 9.Kravos A, Hočevar-Boltežar I, et al. Serum levels of sex hormones in males with Reinke's edema. Eur Arch Otorhinolaryngol. 2013; 270(1): 233-8. https://doi.org/10.1007/s00405-012-2156-7
• 10.Pedersen MF, Møller S, Krabbe S, et al. Fundamental voice frequency in female puberty measured with electroglottography during continuous speech as a secondary sex characteristic. A comparison between voice, pubertal stages, oestrogens and androgens. Int J Pediatr Otorhinolaryngol. 1990; 20(1):17-24. https://doi.org/10.1016/0165-5876(90)90331-K
• 11.Cler GJ, McKenna VS, Dahl KL, et al. Longitudinal Case Study of Transgender Voice Changes Under Testosterone Hormone Therapy. J Voice. 2020; 34(5): 748-62. https://doi.org/10.1016/j.jvoice.2019.03.006
• 12.Glaser R, York A, Dimitrakakis C. Effect of testosterone therapy on the female voice.Climacteric. 2016; 19(2): 198-203. https://doi.org/10.3109/13697137.2015.1136925
• 13.Jost L, Fuchs M, Loeffler M, et al. Associations of Sex Hormones and Anthropometry with the Speaking Voice Profile in the Adult General Popu-lation. J Voice. 2018; 32(3): 261-72. https://doi.org/10.1016/j.jvoice.2017.06.011
• 14.Huang G, Pencina KM, Coady JA, et al. Functional Voice Testing Detects Early Changes in Vocal Pitch in Women During Testosterone Administra-tion. J Clin Endocrinol Metab. 2015; 100(6): 2254-60. https://doi.org/10.1210/jc.2015-1669
• 15.Akcam T, Bolu E, Merati AL, et al. Voice Changes after Androgen Thera-py for Hypogonadotrophic Hypogonadism. Laryngoscope. 2004; 114(9): 1587-91. https://doi.org/10.1097/00005537-200409000-00016
• 16.Hamdan A, Tabet G, Fakhri G, et al. Effect of Hormonal Replacement Therapy on Voice. J Voice. 2018; 32(1): 116-21. https://doi.org/10.1016/j.jvoice.2017.02.019
• 17.Wolters TLC, Roerink SHPP, Drenthen LCA, et al. Voice Characteristics in Patients with Acromegaly during Treatment. J Voice. 2020; S0892-1997(19)30444-8.
• 18.Aydin K, Turkyilmaz D, Ozturk B, et al. Voice characteristics of acro-megaly. Eur Arch Otorhinolaryngol. 2013; 270(4): 1391. https://doi.org/10.1007/s00405-013-2369-4